Inozyme Pharma Inc. (INZY)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
1.41
-0.11 (-7.24%)
At close: Jan 29, 2025, 3:59 PM
1.42
0.71%
After-hours Jan 29, 2025, 07:55 PM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY01 |
PE Ratio | -3.1 | -0.61 | -2.85 | -8.64 | -14.28 | -38.13 | n/a |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 1.57 | 0.33 | 1.47 | 3.05 | -8 | -19.14 | n/a |
P/FCF Ratio | -3.11 | -0.68 | -3.31 | -13.21 | -14.03 | -27.38 | n/a |
P/OCF Ratio | -3.12 | -0.69 | -3.34 | -13.42 | -14.14 | -28.13 | n/a |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.33 | 0.06 | 0.03 | 0.01 | n/a | n/a | n/a |
Quick Ratio | 13.36 | 8.94 | 9.92 | 16.38 | 14.67 | 18.11 | n/a |
Current Ratio | 13.36 | 8.93 | 9.92 | 15.14 | 14.67 | 18.11 | n/a |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | -22.7 | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity (ROE) | -0.51 | -0.55 | -0.52 | -0.35 | 0.56 | 0.50 | n/a |
Return on Assets (ROA) | -0.35 | -0.47 | -0.46 | -0.33 | -0.39 | -0.16 | n/a |
Return on Capital (ROIC) | -0.41 | -0.55 | -0.51 | -0.36 | -0.47 | -0.28 | n/a |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a |